Dr. Barbara Parker graduated from the Stanford University School of Medicine and completed her residency program at the University of California San Diego. She is specialized in Medical Oncology and board certified in Internal Medicine and Oncology. Dr. Parker has been in practice for more than 20 years and is affiliated with the UC San Diego Health System. During her career, she has also contributed to 17 research publications.
Stanford University School of Medicine
University of California San Diego
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.
Sedjo RL, Flatt SW, Byers T, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Wyatt H, Rock CL; Support Care Cancer. 2016-08-01.See more >>
Technology- and Phone-Based Weight Loss Intervention: Pilot RCT in Women at Elevated Breast Cancer Risk.
Hartman SJ, Nelson SH, Cadmus-Bertram LA, Patterson RE, Parker BA, Pierce JP; Am J Prev Med. 2016-11-01.See more >>
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.
de Vries Schultink AHM, Alexi X, van Werkhoven E, Madlensky L, Natarajan L, Flatt SW, Zwart W, Linn SC, Parker BA, Wu AHB, Pierce JP, Huitema ADR, Beijnen JH; Breast Cancer Res. Treat.. 2016-12-22.See more >>
American College of Physicians
American Society of Clinical Oncology